NASDAQ Net Change Percentage Gainers & Losers

Dow Jones05:45
GAINERS 
COMPANY                   SYMBOL      LAST   CHANGE   PERCENT        VOLUME 
-------                   ------      ----   ------   -------        ------ 
 
LOSERS 
COMPANY                   SYMBOL      LAST   CHANGE   PERCENT        VOLUME 
-------                   ------      ----   ------   -------        ------ 
Bicara Therapeutics         BCAX      9.76    -7.72    -44.16    15,385,587 
Oatly Group ADR             OTLY      8.56    -3.19    -27.15     1,261,779 
GrShr 2x Shrt SK Hynix      SKDD      7.53    -2.75    -26.75    11,870,362 
Inhibrx Biosciences         INBX     73.29   -22.37    -23.38     1,186,438 
Materialise ADR             MTLS      6.78    -1.84    -21.35     1,246,452 
F5                          FFIV    365.53   -93.83    -20.43     3,556,547 
Rapport Therapeutics        RAPP     22.50    -5.04    -18.30     5,941,819 
Landstar System             LSTR    138.80   -29.98    -17.76     1,334,222 
Beta Bionics                BBNX     17.85    -3.54    -16.55     2,798,372 
Enphase Energy              ENPH     24.99    -4.77    -16.03    26,580,527 
 
Only includes stocks with a prior day close of $2 a share 
or higher and at least 2,000 shares traded today. 
Data are delayed at least 15 minutes. 
 
Source: WSJ Market Data Group 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment